03/08 | SECTOR UPDATE : Health Care Stocks Hanging on for Modest Gains |  |
03/08 | SECTOR UPDATE : Health Care Stocks Edging Higher This Afternoon |  |
03/08 | SECTOR UPDATE : Health Care Stocks Advance Pre-Bell Wednesday |  |
03/08 | SECTOR UPDATE : Health Care |  |
03/08 | TRANSCRIPT : Horizon Therapeutics Public Limited Company, Q2 2022 Earnings Call, Aug 03, 2.. |  |
03/08 | Horizon Therapeutics Reports Lower Q2 Adjusted Earnings as Sales Rise; Lowers Full-Year.. |  |
03/08 | HORIZON THERAPEUTICS PUBLIC LTD CO MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL C.. |  |
03/08 | HORIZON THERAPEUTICS PUBLIC : plc Reports Second-Quarter 2022 Financial Results and Revise.. |  |
03/08 | HORIZON THERAPEUTICS : Q2 Earnings Snapshot |  |
03/08 | Earnings Flash (HZNP) HORIZON THERAPEUTICS Reports Q2 Revenue $876.4M |  |
03/08 | Earnings Flash (HZNP) HORIZON THERAPEUTICS Reports Q2 EPS $1.07 |  |
03/08 | Horizon Therapeutics Public Limited Company Reports Impairment of Goodwill for the Seco.. |  |
03/08 | Horizon Therapeutics plc Reports Second-Quarter 2022 Financial Results and Revises Full.. |  |
03/08 | Horizon Therapeutics Public Limited Company Reports Earnings Results for the Second Qua.. |  |
03/08 | Horizon Therapeutics Public Limited Company Provides Earnings Guidance for the Full-Yea.. |  |
29/07 | INSIDER SELL : Horizon Therapeutics |  |
25/07 | Horizon Therapeutics plc Named a Best Company for Multicultural Women |  |
21/07 | Horizon Therapeutics plc Announces Inaugural #RAREis Global Advocate Grant Recipients |  |
12/07 | Horizon Therapeutics plc Announces Wanda Durant Has Joined Olympian Gail Devers to Rais.. |  |
11/07 | Horizon Therapeutics plc - FDA Approves KRYSTEXXA Injection Co-Administered With Methot.. |  |
11/07 | Horizon Therapeutics plc Announces Wanda Durant Has Joined Olympian Gail Devers to Rais.. |  |
08/07 | Horizon Therapeutics Says US FDA Approves sBLA for Krystexxa Injection With Methotrexat.. |  |
08/07 | FDA Approves KRYSTEXXA® (pegloticase) Injection Co-Administered With Methotrexate, Expa.. |  |
08/07 | FDA Approves KRYSTEXXA® (pegloticase) Injection Co-Administered With Methotrexate, Expa.. |  |
07/07 | Horizon Therapeutics plc to Release Second-Quarter 2022 Financial Results and Host Webc.. |  |
27/06 | Horizon Therapeutics plc - New Analysis Finds UPLIZNA (inebilizumab) Effective Among Eu.. |  |
24/06 | New Analysis Finds UPLIZNA® (inebilizumab) Effective Among European Populations with Ne.. |  |
24/06 | Horizon Therapeutics Public Limited Company Announces New Analysis Finds UPLIZNA (inebi.. |  |
16/06 | Horizon Therapeutics plc Named One of the Fortune Best Workplaces in Chicago |  |
16/06 | Horizon Therapeutics plc Submits Regulatory Filing for UPLIZNA (inebilizumab) in Brazil |  |
15/06 | Horizon Therapeutics Files for Brazilian Approval of Autoimmune Disease Treatment |  |
15/06 | Horizon Therapeutics plc Submits Regulatory Filing for UPLIZNA® (inebilizumab) in Brazi.. |  |
15/06 | Horizon Therapeutics plc Submits Regulatory Filing for Uplizna® (Inebilizumab) in Brazi.. |  |
15/06 | Horizon Therapeutics plc Named One of the Fortune Best Workplaces in Chicago™ |  |
14/06 | TRANSCRIPT : Horizon Therapeutics Public Limited Company Presents at Goldman Sachs 43rd An.. |  |
13/06 | Horizon Therapeutics plc - Analysis of Pooled Data from TEPEZZA (teprotumumab-trbw) Cli.. |  |
11/06 | Analysis of Pooled Data from TEPEZZA® (teprotumumab-trbw) Clinical Trials Reinforces Sa.. |  |
11/06 | Horizon Therapeutics Public Limited Company Announces Results of A New Analysis Examini.. |  |
09/06 | Horizon Therapeutics plc Named a Top Company for Executive Women |  |
06/06 | Horizon Therapeutics plc to Present at the Goldman Sachs 43rd Annual Global Health Care.. |  |
06/06 | INSIDER SELL : Horizon Therapeutics |  |
03/06 | INSIDER SELL : Horizon Therapeutics |  |
02/06 | Horizon Therapeutics plc - Data Presented from the MIRROR Randomized Controlled Trial D.. |  |
02/06 | Horizon Therapeutics plc to Highlight Data and Education on Thyroid Eye Disease (TED) a.. |  |
01/06 | Horizon Therapeutics plc - Analysis from the Phase 3 N-MOmentum Study Demonstrates the .. |  |
01/06 | Data Presented from the MIRROR Randomized Controlled Trial Demonstrate KRYSTEXXA® (pegl.. |  |
31/05 | Horizon Therapeutics plc Wins 2022 International CSR Excellence Award for #RAREis Adopt.. |  |
31/05 | Analysis from the Phase 3 N-MOmentum Study Demonstrates the Effectiveness of UPLIZNA® (.. |  |
31/05 | Horizon Therapeutics plc Announces Analysis from the Phase 3 N-Momentum Study Demonstra.. |  |
24/05 | Horizon Therapeutics plc to Present MIRROR Randomized Controlled Trial Primary Endpoint.. |  |
17/05 | Horizon Therapeutics Says First Patient Enrolled in Phase 2 Study of Proposed Treatment.. |  |
17/05 | Horizon Therapeutics plc Announces First Patient Enrolled in Phase 2 Trial Evaluating D.. |  |
17/05 | Horizon Therapeutics plc Announces First Patient Enrolled in Phase 2 Trial Evaluating D.. |  |
16/05 | Horizon Therapeutics plc Ranked Second in Overall Corporate Reputation in U.S. PatientV.. |  |
13/05 | INSIDER SELL : Horizon Therapeutics |  |
11/05 | Horizon Therapeutics plc Announces Dara Mann as a Healthcare Businesswomen's Associatio.. |  |
11/05 | Horizon Therapeutics plc Launches Letter-Writing Campaign to Empower Those Living with .. |  |
09/05 | Horizon Therapeutics and Chicago Sky Announce Multi-Year Partnership |  |
04/05 | Horizon Therapeutics Posts Higher Q1 Non-GAAP Earnings, Net Sales |  |
04/05 | TRANSCRIPT : Horizon Therapeutics Public Limited Company, Q1 2022 Earnings Call, May 04, 2.. |  |
04/05 | HORIZON THERAPEUTICS PUBLIC LTD CO MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL C.. |  |
04/05 | HORIZON THERAPEUTICS : Q1 Earnings Snapshot |  |
04/05 | HORIZON THERAPEUTICS PUBLIC LTD CO : Results of Operations and Financial Condition, Change.. |  |
04/05 | Earnings Flash (HZNP) HORIZON THERAPEUTICS Posts Q1 Revenue $885.2M, vs. Street Est of .. |  |
04/05 | Earnings Flash (HZNP) HORIZON THERAPEUTICS Posts Q1 EPS $1.34, vs. Street Est of $1.14 |  |
04/05 | Horizon Therapeutics Public Limited Company Reports Earnings Results for the First Quar.. |  |
04/05 | Horizon Therapeutics Public Limited Company Announces Executive Changes |  |
04/05 | Horizon Therapeutics plc Reports First-Quarter 2022 Financial Results |  |
04/05 | Horizon Therapeutics Public Limited Company Provides Earnings Guidance for the Full Yea.. |  |
03/05 | Horizon Therapeutics Says Phase 2 Trial of Dazodalibep for Rheumatoid Arthritis Met Pri.. |  |
03/05 | Topline Data for Dazodalibep (HZN-4920) Meets Primary Endpoint in Rheumatoid Arthritis |  |
03/05 | Horizon Therapeutics plc Announces Topline Data for Dazodalibep (HZN-4920) Meets Primar.. |  |
02/05 | Horizon Therapeutics plc Launches #RAREis Global Advocate Grant Program to Support the .. |  |
02/05 | HORIZON THERAPEUTICS PUBLIC : AMENDED AND RESTATED 2020 EQUITY INCENTIVE PLAN - Form 8-K |  |
02/05 | HORIZON THERAPEUTICS PUBLIC LTD CO : Change in Directors or Principal Officers, Submission.. |  |